Your browser doesn't support javascript.
loading
Muscarinic inhibition of salivary glands with glycopyrronium bromide does not reduce the uptake of PSMA-ligands or radioiodine.
Mohan, V; Bruin, N M; Tesselaar, M E T; de Boer, J P; Vegt, E; Hendrikx, J J M A; Al-Mamgani, A; van de Kamer, J B; Sonke, J-J; Vogel, W V.
Afiliação
  • Mohan V; Department of Radiation Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands.
  • Bruin NM; Department of Nuclear Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Tesselaar MET; Department of Radiation Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands.
  • de Boer JP; Department of Nuclear Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Vegt E; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Hendrikx JJMA; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Al-Mamgani A; Department of Radiation Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands.
  • van de Kamer JB; Department of Radiology and Nuclear Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Sonke JJ; Department of Radiation Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands.
  • Vogel WV; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
EJNMMI Res ; 11(1): 25, 2021 Mar 12.
Article em En | MEDLINE | ID: mdl-33710423

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: EJNMMI Res Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: EJNMMI Res Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda